Skip to main content
See every side of every news story
Published loading...Updated

BioMed Leaders KRBP, NMLSF, VERU, AIMLF Report Latest Advances in Vaccines, Novel Therapeutics for Oncology, and Autism and HealthTech AI

Summary by Ground News
Wall Street Reporter highlights the latest comments from industry thought leaders shaping our world today, and in the decades ahead. Kiromic BioPharma (NASDAQ: KRBP) CEO Pietro Bersani: Gamma Delta T cell Pipeline Expanding to Five. AI/ML Innovations (OTC: AIMLF) Chairman, Tim Daniels: AI/ML Holds Key Patents for Multi-Billion Dollar Healthcare Wearables Market.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Market Wire News broke the news in United States on Tuesday, June 7, 2022.
Sources are mostly out of (0)

Similar News Topics

News
For You
Search
BlindspotLocal